More than 103,000 people in the U.S. are waiting for an organ transplant, according to the Organ Procurement and Transplantation Network. Nearly 60% of people on transplant waiting lists come from minority communities.
Jan 5, 2024
0
1
Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death worldwide. It is marked by lung damage that is lasting and incurable, leaving lung transplantation as the only viable treatment option. Unfortunately, ...
Jan 5, 2024
0
0
Access to potentially lifesaving heart failure treatments has increased in recent years, but women and Black men remain far less likely to receive them, new research suggests.
Jan 4, 2024
0
1
A large team of medical, psychological and social researchers at University College Cork, in Ireland, working with a colleague from University Hospital Frankfurt, in Germany, has found that certain microbes in the gut biome ...
The world's first partial heart transplant has achieved what researchers have spent more than a year hoping for—functioning valves and arteries that grow along with the young patient, as hypothesized by the pioneering team ...
Jan 3, 2024
0
94
Findings from a study in The American Journal of Pathology reveal that administration of the neuropeptide α-melanocyte–stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise ...
Jan 2, 2024
0
37
Too old and too sick for a heart transplant, Arvid Herrman was given a choice: have a mechanical pump implanted in his heart, potentially keeping him alive for several years, or do nothing and almost certainly die within ...
Jan 1, 2024
0
1
Cedars-Sinai Cancer investigators have discovered a new way to predict whether a cancer of the immune system will recur in patients treated with a bone marrow transplant. Their study, published in the Journal of Clinical ...
Dec 21, 2023
0
0
Transplant recipients, especially those receiving hematopoietic stem cell transplant (HSCT), have an increased risk for vitiligo, according to a brief report published online Dec. 13 in JAMA Dermatology.
Dec 21, 2023
0
0
For patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative conditioning regimen (NMAC) is feasible, ...
Dec 20, 2023
0
1
